Tempus ECG-Low EF vs Aorta-CAD
AI Verdict
Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if your clinical setting requires an AI-powered solution to rapidly screen patients aged 40 or older for signs of low left ventricular ejection fraction (LVEF ≤40%) using standard 12-lead ECG recordings. This tool is ideal for aiding clinicians in identifying individuals at risk of heart failure who may require further cardiac evaluation.
View Tempus ECG-Low EF →Choose Aorta-CAD if…
Choose Aorta-CAD if your practice aims to enhance the detection of Aortic Atherosclerosis and Aortic Ectasia from chest X-rays through an integrated, cloud-based AI solution. This tool is best suited for radiologists and primary care physicians seeking to improve diagnostic accuracy for these specific aortic conditions within their existing imaging workflows.
View Aorta-CAD →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-Low EF | Aorta-CAD |
|---|---|---|
| Deployment | Integrates with current ECG platforms and electronic health records (EHRs). | Cloud-based software that integrates into existing chest X-ray workflows and Picture Archiving and Communication System (PACS) viewers. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Aorta-CADTool B (Aorta-CAD) offers a more direct and interactive user experience by seamlessly integrating into existing X-ray reading workflows with a toggleable overlay for annotations. In contrast, Tool A (Tempus ECG-Low EF) operates without a dedicated user interface, relying on standard communication protocols to integrate with other medical systems for input and output, which may lead to a less direct user interaction.
Clinical Value
Aorta-CADTool B (Aorta-CAD) provides specific, quantifiable clinical outcomes from its studies, demonstrating a 62% relative reduction in misses for aortic calcification and a 35% relative reduction in misses for dilated aorta, with 96% of physicians showing improvement. While Tool A (Tempus ECG-Low EF) is FDA-cleared and trained on a large dataset, its stated performance indicates that LVEF (u226440%) would be observed in approximately 2-in-5 patients with a positive result, which is less impactful than Tool B's demonstrated reduction in diagnostic misses.
Pricing & Value
TieBoth Tool A (Tempus ECG-Low EF) and Tool B (Aorta-CAD) require direct contact with the vendor for pricing information. This lack of transparent pricing for either product makes it impossible to conduct a head-to-head comparison of their value proposition based on cost.
Enterprise Readiness
Aorta-CADBoth tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), indicating strong foundational enterprise readiness. However, Tool B (Aorta-CAD) further demonstrates comprehensive enterprise support through explicit mentions of 'Program Support' covering accreditation, EMR integration, installation management, and 24/7 support, suggesting a more robust and facilitated deployment process.
Innovation
TieBoth tools leverage advanced AI and deep learning algorithms to address significant clinical needs in cardiology, representing substantial innovation in their respective domains. Tool A applies AI to ECGs for LVEF detection, while Tool B uses deep learning for chest X-ray analysis of aortic conditions. Neither demonstrates a fundamentally superior or more novel technological approach compared to the other based on the available information.
Support & Docs
Aorta-CADTool B (Aorta-CAD) explicitly highlights '24/7 emergency support' and a 'single direct phone number and email address directly to our support team,' along with comprehensive program support including training and documentation oversight. Tool A (Tempus ECG-Low EF) provides general customer support contact information and API documentation, but does not detail the same level of dedicated, round-the-clock, and integrated support services.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-Low EF | Aorta-CAD |
|---|---|---|
| Tool Name | Tempus ECG-Low EF | Aorta-CAD |
| Company | Tempus AI | Imagen Technologies |
| Description | FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. | FDA-cleared, cloud-based AI software that assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays, integrating seamlessly into existing workflows. |
| Analyzed Data Type | 12-lead ECG recordings | Chest X-rays |
| Conditions Detected | Signs associated with low Left Ventricular Ejection Fraction (LVEF u226440%) | Signs of Aortic Atherosclerosis and Aortic Ectasia |
| Target Patient Population | Patients 40+ years at risk of heart failure | Not specified |
| Key Output | Binary output (Low LVEF Detected / Not Detected) | Annotations via an overlay that can be toggled on/off |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Internal Medicine, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and Aorta-CAD.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-Low EF or Aorta-CAD
Backers
Who funded each tool's parent company.